Nephro Care India Limited (NSE:NEPHROCARE)
India · Delayed Price · Currency is INR 89.50
+2.60 (2.99%)
At close: Aug 21, 2026
Nephro Care India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,006 | 887.35 | 460.31 | 272.31 | 170.93 | 34.24 |
Other Revenue | - | - | - | -0 | - | - |
| 1,006 | 887.35 | 460.31 | 272.31 | 170.93 | 34.24 | |
Revenue Growth | 84.49% | 92.77% | 69.04% | 59.31% | 399.14% | 87.66% |
Cost of Revenue | 459.55 | 412.1 | 209.12 | 114.39 | 62.29 | 18.7 |
Gross Profit | 546.31 | 475.25 | 251.19 | 157.91 | 108.64 | 15.55 |
Selling, General & Admin | - | - | 28.96 | 12.58 | 9.51 | 3.87 |
Other Operating Expenses | 433.15 | 392.03 | 160.65 | 79.68 | 64.87 | 10.42 |
Operating Expenses | 484.21 | 442.77 | 214.21 | 97.53 | 82.23 | 15.41 |
Operating Income | 62.1 | 32.47 | 36.98 | 60.38 | 26.41 | 0.14 |
Interest Expense | -0.49 | -1.57 | -0.13 | -0.04 | -0.08 | -0.15 |
Interest & Investment Income | 0.54 | - | 1.56 | 0.01 | 0.01 | 0.02 |
Other Non Operating Income (Expenses) | 16.43 | 15.47 | -0.92 | -0.73 | -0.57 | -0.02 |
EBT Excluding Unusual Items | 78.58 | 46.38 | 37.49 | 59.63 | 25.77 | 0 |
Gain (Loss) on Sale of Investments | 0.4 | - | 10.8 | 2.61 | - | - |
Other Unusual Items | - | - | - | -0.91 | - | - |
Pretax Income | 78.98 | 46.38 | 48.29 | 61.32 | 25.77 | 0 |
Income Tax Expense | 22.73 | 12.69 | 11.9 | 17.21 | 2.05 | 0.1 |
Net Income | 56.25 | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Net Income to Common | 56.25 | 33.69 | 36.39 | 44.11 | 23.73 | -0.1 |
Net Income Growth | 196.35% | -7.42% | -17.51% | 85.94% | - | - |
Shares Outstanding (Basic) | 16 | 17 | 15 | 12 | 10 | 4 |
Shares Outstanding (Diluted) | 16 | 17 | 15 | 12 | 10 | 4 |
Shares Change | 3.45% | 8.07% | 29.10% | 18.36% | 181.20% | 1678.08% |
EPS (Basic) | 3.42 | 2.04 | 2.38 | 3.73 | 2.37 | -0.03 |
EPS (Diluted) | 3.42 | 2.04 | 2.38 | 3.73 | 2.37 | -0.03 |
EPS Growth | 186.77% | -14.29% | -36.14% | 57.26% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -55.96 | -219.79 | -23.78 | 36.17 | -22.75 |
Free Cash Flow Per Share | - | -3.39 | -14.38 | -2.01 | 3.62 | -6.40 |
Gross Margin | 54.31% | 53.56% | 54.57% | 57.99% | 63.56% | 45.40% |
Operating Margin | 6.17% | 3.66% | 8.03% | 22.17% | 15.45% | 0.41% |
Profit Margin | 5.59% | 3.80% | 7.90% | 16.20% | 13.88% | -0.29% |
Free Cash Flow Margin | - | -6.31% | -47.75% | -8.73% | 21.16% | -66.44% |
EBITDA | 119.37 | 83.21 | 61.58 | 65.66 | 34.25 | 1.26 |
EBITDA Margin | 11.87% | 9.38% | 13.38% | 24.11% | 20.04% | 3.67% |
D&A For EBITDA | 57.27 | 50.74 | 24.6 | 5.28 | 7.84 | 1.11 |
EBIT | 62.1 | 32.47 | 36.98 | 60.38 | 26.41 | 0.14 |
EBIT Margin | 6.17% | 3.66% | 8.03% | 22.17% | 15.45% | 0.41% |
Effective Tax Rate | 28.78% | 27.37% | 24.65% | 28.06% | 7.94% | 5000.00% |
Revenue as Reported | 1,023 | 902.82 | 475.58 | 276.01 | 170.95 | 34.27 |
Advertising Expenses | - | - | 5.22 | 1.88 | 0.84 | 0.07 |